ask="1.69"
ask_size="600"
average_daily_volume="1847930"
bid="1.52"
bid_size="2000"
book_value="1.98"
change="-0.15"
change_from_200_day_moving_average="-2.00"
change_from_50_day_moving_average="0.01"
change_from_52_week_high="-6.34"
change_From_52_week_low="0.47"
change_in_percent="-8.82%"
close="1.55"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.39"
ebitda="-35.85M"
eps_estimate_current_year="-2.28"
eps_estimate_next_quarter="-0.51"
eps_estimate_next_year="-2.10"
ex_dividend_date="N/A"
float_shares="10213000"
high="1.75"
high_52_weeks="7.89"
last_trade_date="3/17/2017"
last_trade_price="1.55"
last_trade_size="106362"
last_trade_time="4:00pm"
low="1.55"
low_52_weeks="1.08"
market_capitalization="28.91M"
moving_average_200_day="3.55"
moving_average_50_day="1.54"
name="Catabasis Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="6.90"
open="1.75"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-56.30%"
percent_change_from_50_day_moving_average="+0.63%"
percent_change_from_52_week_high="-80.35%"
percent_change_from_52_week_low="+43.52%"
previous_close="1.70"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.86"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="18652000"
short_ratio="0.83"
stock_exchange="NGM"
symbol="CATB"
volume="1418712"
weeks_range_52="1.08 - 7.89"
